Cardiovascular consequences of sickle cell disease
Open Access
- 8 August 2022
- journal article
- review article
- Published by AIP Publishing in Biophysics Reviews
- Vol. 3 (3) , 031302
Abstract
Sickle cell disease (SCD) is an inherited blood disorder caused by a single point mutation within the beta globin gene. As a result of this mutation, hemoglobin polymerizes under low oxygen conditions causing red blood cells to deform, become more adhesive, and increase in rigidity, which affects blood flow dynamics. This process leads to enhanced red blood cell interactions with the endothelium and contributes to vaso-occlusion formation. Although traditionally defined as a red blood cell disorder, individuals with SCD are affected by numerous clinical consequences including stroke, painful crisis episodes, bone infarctions, and several organ-specific complications. Elevated cardiac output, endothelium activation along with the sickling process, and the vaso-occlusion events pose strains on the cardiovascular system. We will present a review of the cardiovascular consequences of sickle cell disease and show connections with the vasculopathy related to SCD. We will also highlight biophysical properties and engineering tools that have been used to characterize the disease. Finally, we will discuss therapies for SCD and potential implications on SCD cardiomyopathy.Keywords
Funding Information
- John S. Dunn Foundation
- Oak Ridge Associated Universities (Ralph E. Powe award)
This publication has 155 references indexed in Scilit:
- A Biophysical Indicator of Vaso-occlusive Risk in Sickle Cell DiseaseScience Translational Medicine, 2012
- Quantifying the Rheological and Hemodynamic Characteristics of Sickle Cell AnemiaBiophysical Journal, 2012
- Plasma thrombospondin‐1 is increased during acute sickle cell vaso‐occlusive events and associated with acute chest syndrome, hydroxyurea therapy, and lower hemolytic ratesAmerican Journal of Hematology, 2011
- A Policy Impact Analysis of the Mandatory NCAA Sickle Cell Trait Screening ProgramHealth Services Research, 2011
- Iron Overload CardiomyopathyJACC, 2010
- Ventricular diastolic dysfunction in sickle cell anemia is common but not associated with myocardial iron depositionPediatric Blood & Cancer, 2010
- Iron Overload in Sickle Cell DiseaseAdvances in Hematology, 2010
- Vasculopathy in sickle cell disease: Biology, pathophysiology, genetics, translational medicine, and new research directionsAmerican Journal of Hematology, 2009
- Sickle Red Cell–Endothelium InteractionsMicrocirculation, 2009
- Heme degradation and oxidative stress in murine models for hemoglobinopathies: Thalassemia, sickle cell disease and hemoglobin C diseaseBlood Cells, Molecules, and Diseases, 2008